uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure

On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease (CNMD) welcomed researchers, trainees and staff to celebrate the research centre’s 25th anniversary.

Founded in 1999 by Dr Bernard Jasmin and Dr Rashmi Kothary, the CNMD has flourished as an interdisciplinary hub of cutting-edge science, evolving into a research hotbed that’s earned a global reputation as a talent-rich innovator, uniting ambitious and talented researchers from the University of Ottawa, The Ottawa Hospital, Ottawa Hospital Research Institute, University of Ottawa Heart Institute, Children’s Hospital of Eastern Ontario (CHEO), and the CHEO Research Institute.

The event highlighted the current groundbreaking neuromuscular research being conducted by investigators at the CNMD and celebrated the enormous growth and international achievements of the CNMD under former co-directors Dr Jodi Warman-Chardon and Dr Robin Parks. The celebration also ushered in the new leadership tenure of Dr Mireille Khacho and Dr Hanns Lochmüller, who see the coming years as a galvanizing time for the field of neuromuscular disease research and view the Centre’s broad community as poised to lead the way. Here’s to another 25 years of research excellence at the CNMD!

Read the full news item from the University of Ottawa Faculty of Medicine

Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

Read next...

New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed...
Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress Congratulations to PhD researcher Kelly Ho, whose poster presentation "Investigating muscle specific kinase antibody treatment...
Clinical trial updates in FSHD

FSHD Clinical Trial Updates

Two clinical trial opportunities in FSHD at The Ottawa NeuroMuscular Centre now recruiting, FSHD community receive negative topline results from phase 3 losmapimod (REACH) trial....